FI940307A0 - Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksi - Google Patents
Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksiInfo
- Publication number
- FI940307A0 FI940307A0 FI940307A FI940307A FI940307A0 FI 940307 A0 FI940307 A0 FI 940307A0 FI 940307 A FI940307 A FI 940307A FI 940307 A FI940307 A FI 940307A FI 940307 A0 FI940307 A0 FI 940307A0
- Authority
- FI
- Finland
- Prior art keywords
- thiazoles
- antidiabetic
- preparation
- chiral intermediates
- chiral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73354891A | 1991-07-22 | 1991-07-22 | |
PCT/US1992/005434 WO1993002061A1 (en) | 1991-07-22 | 1992-07-01 | Chiral intermediates for the preparation of antidiabetics thiazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
FI940307A0 true FI940307A0 (fi) | 1994-01-21 |
FI940307A FI940307A (fi) | 1994-01-21 |
Family
ID=24948077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI940307A FI940307A (fi) | 1991-07-22 | 1994-01-21 | Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksi |
Country Status (17)
Country | Link |
---|---|
US (1) | US5576442A (es) |
EP (1) | EP0641331A1 (es) |
JP (1) | JP2672029B2 (es) |
KR (1) | KR100214907B1 (es) |
AU (1) | AU660187B2 (es) |
CA (1) | CA2111446C (es) |
FI (1) | FI940307A (es) |
HU (1) | HUT70422A (es) |
IE (1) | IE922358A1 (es) |
IL (1) | IL102575A (es) |
MX (1) | MX9204277A (es) |
NO (1) | NO940226D0 (es) |
NZ (1) | NZ243652A (es) |
PT (1) | PT100709B (es) |
TW (1) | TW199892B (es) |
WO (1) | WO1993002061A1 (es) |
ZA (1) | ZA925470B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687149B1 (fr) * | 1992-02-12 | 1995-11-03 | Roussel Uclaf | Nouveaux esters pyrethrinouides derives d'alcools thiazoliques, leur procede de preparation et leur application comme pesticides. |
EP0708764A1 (en) * | 1993-07-16 | 1996-05-01 | Pfizer Inc. | Enanthioselective preparation of thiazole derivatives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3621775A1 (de) * | 1986-03-13 | 1988-01-07 | Thomae Gmbh Dr K | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US4886814A (en) * | 1986-03-13 | 1989-12-12 | Dr. Karl Thomas Gmbh | Substituted thiazoles and oxazoles and 2-hydroxy-morpholines |
US4943635A (en) * | 1987-08-27 | 1990-07-24 | President & Fellows Of Harvard College | Enantioselective reduction of ketones |
US5036079A (en) * | 1989-12-07 | 1991-07-30 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
EP0595868B1 (en) * | 1991-07-22 | 1998-11-25 | Pfizer Inc. | Process for the preparation of (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl]bromobenzene |
-
1992
- 1992-07-01 HU HU9400187A patent/HUT70422A/hu unknown
- 1992-07-01 CA CA002111446A patent/CA2111446C/en not_active Expired - Fee Related
- 1992-07-01 KR KR1019940700182A patent/KR100214907B1/ko not_active IP Right Cessation
- 1992-07-01 US US08/162,036 patent/US5576442A/en not_active Expired - Fee Related
- 1992-07-01 WO PCT/US1992/005434 patent/WO1993002061A1/en not_active Application Discontinuation
- 1992-07-01 JP JP5502811A patent/JP2672029B2/ja not_active Expired - Fee Related
- 1992-07-01 AU AU23063/92A patent/AU660187B2/en not_active Ceased
- 1992-07-01 EP EP92914850A patent/EP0641331A1/en not_active Withdrawn
- 1992-07-07 TW TW081105397A patent/TW199892B/zh active
- 1992-07-20 PT PT100709A patent/PT100709B/pt not_active IP Right Cessation
- 1992-07-21 ZA ZA925470A patent/ZA925470B/xx unknown
- 1992-07-21 IL IL10257592A patent/IL102575A/en not_active IP Right Cessation
- 1992-07-21 MX MX9204277A patent/MX9204277A/es not_active IP Right Cessation
- 1992-07-21 NZ NZ243652A patent/NZ243652A/en unknown
- 1992-07-21 IE IE235892A patent/IE922358A1/en not_active Application Discontinuation
-
1994
- 1994-01-21 NO NO940226A patent/NO940226D0/no unknown
- 1994-01-21 FI FI940307A patent/FI940307A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
IL102575A0 (en) | 1993-01-14 |
IL102575A (en) | 1996-03-31 |
PT100709A (pt) | 1993-09-30 |
FI940307A (fi) | 1994-01-21 |
NZ243652A (en) | 1994-02-25 |
JPH06505026A (ja) | 1994-06-09 |
ZA925470B (en) | 1994-01-21 |
CA2111446C (en) | 1997-12-16 |
WO1993002061A1 (en) | 1993-02-04 |
NO940226L (no) | 1994-01-21 |
EP0641331A1 (en) | 1995-03-08 |
US5576442A (en) | 1996-11-19 |
MX9204277A (es) | 1993-02-01 |
KR100214907B1 (ko) | 1999-08-02 |
TW199892B (es) | 1993-02-11 |
IE922358A1 (en) | 1993-01-27 |
AU660187B2 (en) | 1995-06-15 |
HU9400187D0 (en) | 1994-05-30 |
HUT70422A (en) | 1995-10-30 |
JP2672029B2 (ja) | 1997-11-05 |
AU2306392A (en) | 1993-02-23 |
PT100709B (pt) | 1999-07-30 |
NO940226D0 (no) | 1994-01-21 |
CA2111446A1 (en) | 1993-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI954768A (fi) | Välituotteina käyttökelpoiset 4-syklopropyylimetoksipyridiiniyhdisteet | |
FI962599A0 (fi) | Enantioselektiivinen menetelmä kiraalisten triaryylijohdannaisten ja niiden valmistuksessa käytettävien kiraalisten välituotteiden valmistamiseksi | |
FI940769A0 (fi) | Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi | |
FI103666B1 (fi) | Menetelmä bifenyylijohdannaisen valmistamiseksi | |
FI942907A (fi) | Menetelmä lipaasin valmistamiseksi | |
FI952585A0 (fi) | Menetelmä bentsopyraaniyhdisteiden valmistamiseksi | |
FI954272A0 (fi) | Menetelmä akryylipiperidiinikarbinolien valmistamiseksi | |
FI960254A (fi) | Menetelmä N-(4-hydroksifenyyli)-retiiniamidin valmistamiseksi | |
FI893003A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi | |
FI902316A0 (fi) | Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä | |
EE9400257A (et) | Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks | |
FI98461B (fi) | Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi | |
BR9206293A (pt) | Tiazolidinadionas hipoglicêmicas e intermediários | |
FI911701A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi | |
FI940307A0 (fi) | Kiraalivälituotteet antidiabettisten tiatsolien valmistamiseksi | |
FI892144A (fi) | Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi | |
FI102841B1 (fi) | Menetelmä mannitolin valmistamiseksi | |
FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi | |
FI940551A (fi) | Menetelmä fenyylibentsamidijohdannaisten valmistamiseksi | |
FI971964A0 (fi) | Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi | |
FI951441A (fi) | Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi | |
DE59309038D1 (de) | Chlorthiazolderivate | |
FI964117A0 (fi) | Menetelmä uusien 1-asyylipiperidiiniyhdisteiden valmistamiseksi | |
FI960180A0 (fi) | Tiatsolijohdannaisten enantioselektiivinen valmistus | |
NO177592C (no) | Nye mellomprodukter for fremstilling av carbapenemderivater |